Rani Therapeutics Holdings, Inc. (RANI)
RANI Stock Price Chart
Explore Rani Therapeutics Holdings, Inc. interactive price chart. Choose custom timeframes to analyze RANI price movements and trends.
RANI Company Profile
Discover essential business fundamentals and corporate details for Rani Therapeutics Holdings, Inc. (RANI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Jul 2021
Employees
105.00
Website
https://www.ranitherapeutics.comCEO
Talat Imran
Description
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.
RANI Financial Timeline
Browse a chronological timeline of Rani Therapeutics Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.09.
Earnings released on 7 Aug 2025
EPS came in at -$0.18 surpassing the estimated -$0.19 by +5.26%.
Earnings released on 13 May 2025
EPS came in at -$0.22 matching the estimated -$0.22, while revenue for the quarter reached $172.00K .
Earnings released on 31 Mar 2025
EPS came in at -$0.27 falling short of the estimated -$0.24 by -12.50%, while revenue for the quarter reached $1.03M .
Earnings released on 14 Nov 2024
EPS came in at -$0.24 falling short of the estimated -$0.22 by -9.09%.
Earnings released on 6 Aug 2024
EPS came in at -$0.26 surpassing the estimated -$0.29 by +10.34%.
Earnings released on 6 May 2024
EPS came in at -$0.29 falling short of the estimated -$0.23 by -26.09%.
Earnings released on 20 Mar 2024
EPS came in at -$0.27 surpassing the estimated -$0.31 by +12.90%, while revenue for the quarter reached $2.75M .
Earnings released on 8 Nov 2023
EPS came in at -$0.36 surpassing the estimated -$0.47 by +23.40%.
Earnings released on 11 Aug 2023
EPS came in at -$0.37 surpassing the estimated -$0.40 by +7.50%.
Earnings released on 10 May 2023
EPS came in at -$0.33 surpassing the estimated -$0.47 by +29.79%.
Earnings released on 22 Mar 2023
EPS came in at -$0.35 falling short of the estimated -$0.26 by -34.62%.
Earnings released on 10 Nov 2022
EPS came in at -$0.33 matching the estimated -$0.33.
Earnings released on 10 Aug 2022
EPS came in at -$0.31 falling short of the estimated -$0.28 by -10.71%.
Earnings released on 11 May 2022
EPS came in at -$0.29 surpassing the estimated -$1.00 by +71.00%.
Earnings released on 29 Mar 2022
EPS came in at -$0.27 surpassing the estimated -$1.28 by +78.91%, while revenue for the quarter reached -$2.72M , missing expectations by -1.77K%.
Earnings released on 15 Nov 2021
EPS came in at -$0.16 surpassing the estimated -$0.21 by +23.81%.
Earnings released on 13 Sept 2021
EPS came in at -$0.12 surpassing the estimated -$0.18 by +33.33%, while revenue for the quarter reached $1.96M .
Earnings released on 2 Aug 2021
EPS came in at -$0.30 , while revenue for the quarter reached $756.00K .
Earnings released on 31 Dec 2020
EPS came in at -$0.89 , while revenue for the quarter reached $210.00K .
Earnings released on 30 Sept 2020
EPS came in at -$0.15 , while revenue for the quarter reached $108.00K .
RANI Stock Performance
Access detailed RANI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.